The HIV treatment landscape has further evolved with the introduction of LAI therapies, offering alternatives to daily oral ...

SAN FRANCISCO — The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, a population at greater risk for acquiring HIV ...

April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...

Immune therapy works as well in senior cancer patients as in younger adults Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the ...

Core Facility Functional Peptidomics, Ulm University Medical Center, 89081 Ulm, Germany Core Unit Mass Spectrometry and Proteomics, Ulm University Medical Center, 89081 Ulm, Germany ...

Synthetic Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States ...

HIV drugs have revolutionized the management ... which is expected to reach US$29 Billion by 2030 with a CAGR of a 5.2%. The Integrase Inhibitors (INIs) segment is also set to grow at 5.7% CAGR ...

Inhibitors of Apoptosis Proteins (IAPs) are a family of anti-apoptotic proteins that play a pivotal role in apoptosis in general but also as oncoproteins in cancer progression and, more importantly, ...

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...

Four non-nucleoside RT inhibitors (NNRTIs) were developed between 1996 and 2008. Nevirapine and efavirenz are recommended as key drugs in the latest first-line regimens. NNRTIs bind to a ...